Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Great Tree Pharmacy CoROCO:6469 +2.19%70 Earnings Yield (Joel Greenblatt) % is 4.23% as of Jun. 2026, which is 21% above its 10-year median of 3.49. GuruFocus rates ROCO:6469 with a GF Score™ of 70/100 and a GF Value™ of NT$152.49 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 682 Healthcare Providers & Services companies, Great Tree Pharmacy Co ranks better than 54.99% on this metric.
Great Tree Pharmacy Co's Enterprise Value for the quarter that ended in Jun. 2026 was NT$16,595 Mil.
Great Tree Pharmacy Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was NT$701 Mil. Great Tree Pharmacy Co's Earnings Yield (Joel Greenblatt) for the quarter that ended in Jun. 2026 was 4.23%.
The historical rank and industry rank for Great Tree Pharmacy Co's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
ROCO:6469'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: 1.52 Med: 3.49 Max: 6.28
Current: 4.61
During the past 13 years, the highest Earnings Yield (Joel Greenblatt) of Great Tree Pharmacy Co was 6.28%. The lowest was 1.52%. And the median was 3.49%.
ROCO:6469's Earnings Yield (Joel Greenblatt) % is ranked better than 54.99% of 682
companies
in the Healthcare Providers & Services industry
Industry Median: 3.855
vs ROCO:6469: 4.61
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Great Tree Pharmacy Co's Forward Rate of Return (Yacktman) % for the quarter that ended in Jun. 2026 was 16.45%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Great Tree Pharmacy Co (ROCO:6469) Earnings Yield (Joel Greenblatt) % Explanation
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
Great Tree Pharmacy Co Earnings Yield (Joel Greenblatt) % Related Terms
Great Tree Pharmacy Co Earnings Yield (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Great Tree Pharmacy Co's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Great Tree Pharmacy Co Earnings Yield (Joel Greenblatt) % Chart
Great Tree Pharmacy Co Earnings Yield (Joel Greenblatt) % Competitor Comparison
For the Pharmaceutical Retailers subindustry, Great Tree Pharmacy Co's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Great Tree Pharmacy Co Earnings Yield (Joel Greenblatt) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Great Tree Pharmacy Co's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Great Tree Pharmacy Co's Earnings Yield (Joel Greenblatt) % falls into.
Great Tree Pharmacy Co Earnings Yield (Joel Greenblatt) % Calculation
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
Great Tree Pharmacy Cos Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2025 is calculated as
Great Tree Pharmacy Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$701 Mil.
What does a Earnings Yield (Joel Greenblatt) % of 4.23% mean?
Great Tree Pharmacy Co (ROCO:6469) has a Earnings Yield (Joel Greenblatt) % of 4.23% as of Jun. 2026. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Great Tree Pharmacy Co and its competitors. This is 21% above median its historical median of 3.49. Over the past decade, Great Tree Pharmacy Co's Earnings Yield (Joel Greenblatt) % has ranged from 1.52 to 6.28. According to the industry distribution chart, Great Tree Pharmacy Co ranks #307 out of 682 companies in the Healthcare Providers & Services industry, placing it in the top 45%.
Is Great Tree Pharmacy Co's Earnings Yield (Joel Greenblatt) % too high?
Great Tree Pharmacy Co's current Earnings Yield (Joel Greenblatt) % of 4.23% is 21% above median its 10-year median of 3.49. Over the past 10 years, this metric has ranged from a low of 1.52 to a high of 6.28. The Healthcare Providers & Services industry median Earnings Yield (Joel Greenblatt) % is 3.86. Great Tree Pharmacy Co's value of 4.23% is 9.7% above this industry median. Based on the distribution chart, Great Tree Pharmacy Co ranks #307 out of 682 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Great Tree Pharmacy Co has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Great Tree Pharmacy Co's Earnings Yield (Joel Greenblatt) % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Great Tree Pharmacy Co ranks #307 out of 682 companies for Earnings Yield (Joel Greenblatt) %. This puts Great Tree Pharmacy Co in the upper half of its industry. The industry median Earnings Yield (Joel Greenblatt) % is 3.86. Great Tree Pharmacy Co's value of 4.23% is 9.7% above this benchmark. Historically, Great Tree Pharmacy Co's own Earnings Yield (Joel Greenblatt) % has ranged from 1.52 to 6.28 over the past decade. While the company's 10-year median is 3.49 vs. the industry median of 3.86, Great Tree Pharmacy Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median Earnings Yield (Joel Greenblatt) % among Healthcare Providers & Services companies is 3.86, based on 682 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Great Tree Pharmacy Co's current Earnings Yield (Joel Greenblatt) % of 4.23% is 9.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Great Tree Pharmacy Co and its competitors. For the Healthcare Providers & Services industry, the median Earnings Yield (Joel Greenblatt) % is 3.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Great Tree Pharmacy Co's current Earnings Yield (Joel Greenblatt) % is 4.23%, which is 21% above median its own 10-year median of 3.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Great Tree Pharmacy Co stock overvalued right now?
Based on GuruFocus' analysis, Great Tree Pharmacy Co (ROCO:6469) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$152.49, compared to a current price of NT$64.50 — trading 57.7% below its estimated fair value. The current Earnings Yield (Joel Greenblatt) % is 4.23%, which is 21% above median its 10-year median of 3.49 and 9.7% above the Healthcare Providers & Services industry median of 3.86. Great Tree Pharmacy Co's overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For Great Tree Pharmacy Co (ROCO:6469), the current Earnings Yield (Joel Greenblatt) % is 4.23% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Great Tree Pharmacy Co (ROCO:6469) Overvalued in 2026?
Based on GuruFocus' analysis, Great Tree Pharmacy Co stock appears to be undervalued.
The current stock price of NT$64.50 is trading 57.7% below its estimated GF Value™ of NT$152.49.
GuruFocus considers Great Tree Pharmacy Co to be Significantly Undervalued.
Key valuation signals for ROCO:6469:
Earnings Yield (Joel Greenblatt) %: 4.23% (21% above median its 10-year median of 3.49)
GF Value™: NT$152.49 vs. price of NT$64.50 (57.7% below fair value)
Industry Position: 9.7% above the Healthcare Providers & Services median (#307 of 682)
No single metric tells the full story. See the ROCO:6469 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Great Tree Pharmacy Co Ltd engages in management and trading of various drugs, health supplements, maternity and infant products, and cosmetics products. It also provides coordinated medicine procurement services to various clinics, outpatient centers, and medical communities. Besides, it is also an agency for domestic and foreign health care products sold in clinics, outpatient centers, and medical communities. Its products include infant formula, baby diapers, Maternal and Infant Related, Adult drinks, Nutrition and health care, Body care, Daily Necessities, medical equipment, and Pet products.
70GF Score
Get the complete analysis for ROCO:6469
Earnings Yield (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6469 has been successfully added to your 
